Extract
Marie Curie is a legendary figure: her research had huge impact on medicine, and she was the first woman to receive a Nobel Prize. In fact, she received two, one in Physics in 1903, and one in Chemistry in 1911, and so early in the history of Nobel Prizes (they were first awarded in 1901) a woman was a laureate. This was before women's suffrage in most parts of the world, and before any notion of gender equality, when few women had a chance to follow a career in science or medicine or get any education, and Marie Curie showed that it was possible. She was admired, respected and a role model for women in science. But still, more than 100 years later, few women have followed her footsteps: Between 1901 and 2018, there have been 902 Nobel laureates and of those, 52 were women [1].
一个bstract
Few women are still promoted to leadership positions and there seems to be an unconscious bias that must be changedhttp://bit.ly/2mET3t6
Footnotes
Conflict of interest: M. Gaga reports lecture fees and departmental grants from AZ, Novartis, GSK, Chiesi, Menarini, Roche, BMS, MSD and Galapagos, outside of the submitted work.
Conflict of interest: D. Stolz reports lecture fees from AstraZeneca AG, Novartis AG, GSK AG, Roche AG, Zambon, Pfizer, Schwabe Pharma AG and Vifor AG, outside the submitted work.
利益冲突:j . Chorostowska-Wynimko回购rts grants, personal fees and non-financial support from CSL Behring, Grifols, AstraZeneca, Boehringer Ingelheim and CelonPharma, personal fees and non-financial support from Pfizer, MSD, BMS and Abbvie, personal fees from GSK, Kamada, Novartis, Chiesi, Lekam, Takeda and Angelini.
Conflict of interest: T. Welte has nothing to disclose.
Conflict of interest: A. Simonds has nothing to disclose.
- ReceivedSeptember 18, 2019.
- 一个cceptedSeptember 18, 2019.
- Copyright ©ERS 2020